Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Mitos.Therapeutics Logo
Mitos.Therapeutics Growth Score
13
CB Rank
892506
Heat Score
58
Mitos.Therapeutics is a biotech company specializing in the development of mitochondrial-based anti-metabolic syndrome and cancer drugs.
Founded
obfuscation
PrivateSeed Daejeon, Taejon-jikhalsi, South Korea1-10 www.mitos-thera.com
Biotechnology
Clinical Trials
Therapeutics
Overview

Mitos.Therapeutics
Growth Score
13
Heat Score
58

Growth Score13
-3 pts
in past quarter
Heat Score 58
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Mitos.Therapeutics

CB Rank
892506
Mitos.Therapeutics is a biotech company specializing in the development of mitochondrial-based anti-metabolic syndrome and cancer drugs.
Founded
obfuscation
PrivateSeed Daejeon, Taejon-jikhalsi, South Korea1-10 www.mitos-thera.com
Biotechnology
Clinical Trials
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name Mitos Therapautics Inc.
Operating Status Active
Company Type For Profit
Phone Number +82 42 825 6702
Contact Email insulin@mitos-thera.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Mitochondrial-based Anti-Metabolic Syndrome Drugs
Drugs developed to target mitochondrial functions to treat metabolic syndrome conditions such as obesity, diabetes, and fatty liver disease.
Mitochondrial-based Anti-Cancer Drugs
Pharmaceutical compounds designed to target mitochondrial metabolism in cancer cells to inhibit tumor growth and progression.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Mitos.Therapeutics Logo
Seed Round - Mitos.Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - Mitos.Therapeutics Logo
Seed Round - Mitos.Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - Mitos.Therapeutics Logo
Seed Round - Mitos.Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - Mitos.Therapeutics Logo
Seed Round - Mitos.Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - Mitos.Therapeutics Logo
Seed Round - Mitos.Therapeutics
1
obfuscation
— Seed

Funding Rounds

Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Mitos.Therapeutics Logo
Seed Round - Mitos.Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - Mitos.Therapeutics Logo
Seed Round - Mitos.Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - Mitos.Therapeutics Logo
Seed Round - Mitos.Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - Mitos.Therapeutics Logo
Seed Round - Mitos.Therapeutics
1
obfuscation
— Seed
obfuscation
Seed Round - Mitos.Therapeutics Logo
Seed Round - Mitos.Therapeutics
1
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News
Technology
View Tech Report

Monthly Web Visits

357
-17.86%
 in past month

Active Website Tech Count

5Mitos.Therapeutics is actively using 5 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.

Total IP

5The intellectual property of Mitos.Therapeutics includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Mitos.Therapeutics has registered 2 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Mitos.Therapeutics's headquarters? Mitos.Therapeutics is located in Daejeon, Taejon-jikhalsi, South Korea.Who invested in Mitos.Therapeutics? Mitos.Therapeutics has 3 investors including Chungnam National University and  TIPS Program.When was the last funding round for Mitos.Therapeutics? Mitos.Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Mitos.Therapeutics's competitors? Alternatives and possible competitors to Mitos.Therapeutics may include Aardvark Therapeutics, Fractyl Health, and  Structure Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|